Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.39 trillion and total revenue of $115.78 billion.
Market Cap
1.39T
Revenue
115.78B
Profits
-39.71B
PE Ratio
n/a
Profit Margin
-34.29%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.79B | 1.36% | 635,121 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.49B | 1.15% | 494,954 | 15.53B |
| 3 | ARGX | argenx SE | 64.66B | 0.72% | 223,958 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 58.59B | 10.08% | 78,851,363 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.81B | -1.27% | 1,002,737 | - |
| 6 | ONC | BeOne Medicines AG | 42.74B | 1.83% | 155,554 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.31B | 1.35% | 1,564,690 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.57B | 2.88% | 1,292,654 | 4.80B |
| 9 | BNTX | BioNTech SE | 29.08B | 4.38% | 2,446,991 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.54B | 0.84% | 577,920 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.38B | -0.87% | 3,589,060 | 7.53M |
| 12 | INCY | Incyte Corporation | 26.02B | 0.92% | 694,660 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.06B | -0.15% | 1,718,005 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.82B | 0.51% | 222,974 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.52B | 2.34% | 318,843 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.09B | -0.80% | 1,170,484 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.43B | 0.99% | 759,821 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.07B | -0.08% | 398,051 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.95B | -1.15% | 891,054 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.28B | 1.96% | 760,594 | 1.66B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.22B | -1.06% | 643,104 | 669.50M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.97B | -0.20% | 86,862 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.34B | 0.05% | 3,230,872 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.95B | -1.05% | 546,265 | 5.67M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.94B | 0.42% | 432,408 | 776.57M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.76B | 0.26% | 795,998 | 67.67M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 10.51B | 3.27% | 280,015 | 7.46M |
| 28 | SMMT | Summit Therapeutics Inc. | 10.46B | 5.47% | 5,054,041 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 10.23B | 2.55% | 104,761 | 440.48M |
| 30 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.04% | 701,785 | - |
| 31 | KYMR | Kymera Therapeutics, Inc. | 10.06B | -0.44% | 271,677 | 105.00M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 9.93B | 1.80% | 243,573 | 281.99M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.92B | 1.62% | 1,768,068 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.39B | -1.16% | 531,809 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.37B | 2.64% | 817,844 | - |
| 36 | IMVT | Immunovant, Inc. | 9.12B | -0.47% | 510,462 | - |
| 37 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.06% | 940,131 | 42.16M |
| 38 | IBRX | ImmunityBio, Inc. | 8.07B | -2.93% | 5,501,940 | 165.79M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.75B | 8.05% | 4,062,514 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.60B | 1.28% | 365,442 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.45B | 7.28% | 4,721,925 | 989.61M |
| 42 | ORKA | Oruka Therapeutics, Inc. | 7.16B | 3.19% | 412,427 | - |
| 43 | CGON | CG Oncology, Inc. | 7.04B | 2.39% | 408,810 | 6.23M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.87B | 2.17% | 700,549 | - |
| 45 | BLTE | Belite Bio, Inc | 6.53B | 0.17% | 68,806 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 6.36B | 3.79% | 1,592,473 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.29B | -0.23% | 516,784 | 618.07M |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 6.22B | 1.62% | 540,265 | 1.90M |
| 49 | TVTX | Travere Therapeutics, Inc. | 6.19B | 1.88% | 777,410 | 591.33M |
| 50 | ERAS | Erasca, Inc. | 6.16B | 3.10% | 1,200,549 | - |
| 51 | DFTX | Definium Therapeutics, Inc. | 6.06B | -0.62% | 843,978 | - |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.90B | 2.03% | 551,731 | 7.50M |
| 53 | PTCT | PTC Therapeutics, Inc. | 5.86B | -0.44% | 313,268 | 1.01B |
| 54 | CRSP | CRISPR Therapeutics AG | 5.80B | 3.29% | 1,980,950 | 13.39M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | 0.23% | 77,989 | 290.54M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | 1.45% | 631,106 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.91B | 1.23% | 680,273 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.87B | -0.43% | 279,526 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.79B | 1.78% | 610,750 | - |
| 60 | CELC | Celcuity Inc. | 4.61B | 4.05% | 454,623 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.34B | 0.58% | 374,388 | - |
| 62 | MANE | Veradermics, Incorporated | 4.31B | -1.97% | 255,205 | - |
| 63 | LEGN | Legend Biotech Corporation | 4.25B | 3.10% | 785,258 | 1.27B |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.25B | -1.62% | 1,582,048 | 10.35M |
| 65 | TNGX | Tango Therapeutics, Inc. | 4.00B | 0.81% | 1,557,749 | 53.81M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.97B | -0.56% | 373,882 | 3.60M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.93B | -1.99% | 972,417 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.85B | 2.44% | 734,400 | 117.00M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.81B | 0.92% | 578,638 | 234.13M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.80B | -8.70% | 258,121 | 890.79M |
| 71 | IOVA | Iovance Biotherapeutics, Inc. | 3.77B | -7.45% | 23,676,781 | 324.97M |
| 72 | ABCL | AbCellera Biologics Inc. | 3.67B | -2.20% | 3,696,424 | 66.17M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.56B | -1.23% | 384,916 | - |
| 74 | QURE | uniQure N.V. | 3.37B | -0.53% | 451,961 | 18.67M |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.18% | 314,348 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.24B | 1.64% | 570,164 | 4.02M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 3.20B | 2.00% | 547,969 | 158.00K |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 3.18B | 1.41% | 335,694 | 606.33M |
| 79 | MBX | MBX Biosciences, Inc. | 3.17B | -0.72% | 259,355 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -0.99% | 1,091,497 | 463.98M |
| 81 | ALMS | Alumis Inc. | 3.13B | 5.64% | 590,176 | 7.40M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 3.10B | 14.63% | 12,984,648 | - |
| 83 | IRON | Disc Medicine, Inc. | 3.04B | 0.41% | 255,891 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.95B | 4.12% | 1,854,981 | 156.04M |
| 85 | ZLAB | Zai Lab Limited | 2.92B | 0.12% | 710,143 | 449.61M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.81B | 0.11% | 1,007,948 | 36.77M |
| 87 | ATAI | AtaiBeckley Inc. | 2.75B | -0.07% | 3,446,547 | 4.47M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.74B | -1.27% | 517,399 | 71.13M |
| 89 | PHVS | Pharvaris N.V. | 2.57B | 0.44% | 352,381 | - |
| 90 | PGEN | Precigen, Inc. | 2.56B | -3.83% | 2,924,940 | 85.72M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -1.48% | 714,863 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 2.73% | 1,719,278 | 717.00M |
| 93 | NKTR | Nektar Therapeutics | 2.51B | -1.38% | 387,816 | 54.59M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.43B | -0.27% | 2,075,044 | 52.06M |
| 95 | NUVB | Nuvation Bio Inc. | 2.43B | 1.24% | 4,185,355 | 169.90M |
| 96 | KOD | Kodiak Sciences Inc. | 2.41B | -3.71% | 345,905 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 2.34B | 4.00% | 931,919 | - |
| 98 | RAPP | Rapport Therapeutics, Inc. | 2.31B | 0.77% | 72,317 | 20.00M |
| 99 | URGN | UroGen Pharma Ltd. | 2.29B | 0.20% | 525,519 | 188.73M |
| 100 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 1.66% | 289,039 | - |
| 101 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | 0.23% | 440,561 | - |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.25B | 4.70% | 6,462,142 | 208.78M |
| 103 | KLRA | Kailera Therapeutics, Inc. | 2.25B | -0.46% | 255,983 | - |
| 104 | NBTX | Nanobiotix S.A. | 2.25B | 0.41% | 62,293 | 38.27M |
| 105 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | 0.42% | 218,664 | 959.90M |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -3.18% | 932,419 | 311.51M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.20B | 0.72% | 868,495 | 512.28M |
| 108 | MESO | Mesoblast Limited | 2.20B | -2.93% | 127,055 | 65.38M |
| 109 | VCEL | Vericel Corporation | 2.18B | 1.20% | 321,845 | 306.30M |
| 110 | BHVN | Biohaven Ltd. | 2.13B | 4.52% | 1,392,921 | - |
| 111 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 0.85% | 390,175 | 1.00M |
| 112 | GENB | Generate Biomedicines, Inc. | 2.08B | 1.25% | 654,746 | 26.48M |
| 113 | STOK | Stoke Therapeutics, Inc. | 2.07B | 2.29% | 385,958 | 27.59M |
| 114 | XNCR | Xencor, Inc. | 2.06B | 2.48% | 466,629 | 104.97M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 2.02B | -1.89% | 116,915 | - |
| 116 | ZYME | Zymeworks Inc. | 2.00B | 6.04% | 397,621 | 37.13M |
| 117 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | -1.93% | 861,155 | 1.97B |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -1.31% | 346,814 | 98.34M |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | -1.23% | 795,083 | 5.49M |
| 120 | GHRS | GH Research PLC | 1.96B | -0.52% | 81,005 | - |
| 121 | KARD | Kardigan, Inc. | 1.95B | 3.01% | 112,446 | - |
| 122 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.05% | 1,936,626 | - |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 1.77% | 184,994 | 1.13B |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.90B | 1.72% | 88,089 | - |
| 125 | SEPN | Septerna, Inc. | 1.89B | -0.54% | 166,362 | 98.88M |
| 126 | IMCR | Immunocore Holdings plc | 1.89B | 1.24% | 225,315 | 430.78M |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | 5.09% | 19,585,758 | 54.86M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.81B | 4.02% | 2,274,999 | 59.51M |
| 129 | BRVE | Braveheart Bio, Inc. | 1.77B | 0.40% | 89,655 | - |
| 130 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.46% | 719,144 | 252.25M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.74B | 0.82% | 447,800 | 2.68B |
| 132 | AVLN | Avalyn Pharma Inc. | 1.74B | 5.79% | 105,269 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.71B | 1.69% | 190,411 | 232.39M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.65B | 5.75% | 1,176,631 | 303.23M |
| 135 | ABSI | Absci Corporation | 1.65B | 3.39% | 1,731,861 | 1.56M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.64B | 2.04% | 159,655 | 20.00M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.59B | -1.72% | 353,324 | - |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.56B | 1.63% | 163,978 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.54B | -0.92% | 839 | 94.61M |
| 140 | LBRX | LB Pharmaceuticals Inc | 1.54B | 1.14% | 133,847 | - |
| 141 | APMD | Apnimed, Inc. | 1.54B | -2.70% | 185,714 | 120.15M |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.53B | 2.03% | 266,381 | - |
| 143 | INVA | Innoviva, Inc. | 1.53B | 0.62% | 289,518 | 440.00M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.51B | 3.35% | 176,701 | 1.30M |
| 145 | SLBT | SL Science Holding Limited | 1.51B | -2.58% | 23,841 | 3.27M |
| 146 | NVAX | Novavax, Inc. | 1.49B | 7.36% | 8,570,723 | 413.80M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.45B | 0.94% | 408,753 | - |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 0.43% | 138,258 | - |
| 149 | SVRA | Savara Inc. | 1.41B | 0.91% | 1,047,241 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.40B | 3.50% | 111,172 | - |
| 151 | VOR | Vor Biopharma Inc. | 1.39B | 1.93% | 409,386 | - |
| 152 | OMER | Omeros Corporation | 1.39B | 2.84% | 1,697,668 | 38.42M |
| 153 | REPL | Replimune Group, Inc. | 1.39B | 4.70% | 2,142,073 | - |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | 0.70% | 587,356 | - |
| 155 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 4.18% | 471,221 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.37B | -1.79% | 370,664 | 397.50M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.36B | 0.94% | 419,509 | - |
| 158 | MNKD | MannKind Corporation | 1.36B | -0.70% | 2,012,663 | 393.63M |
| 159 | AKTS | Aktis Oncology, Inc. | 1.36B | 1.83% | 155,406 | 10.06M |
| 160 | ANRO | Alto Neuroscience, Inc. | 1.34B | -0.16% | 173,165 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.33B | -1.45% | 823,528 | - |
| 162 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 1.85% | 54,852 | - |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 1.24B | 4.74% | 131,712 | 99.00K |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -2.84% | 532,154 | 28.73M |
| 165 | IMTX | Immatics N.V. | 1.22B | 4.09% | 337,064 | 47.65M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 0.84% | 290,310 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 1.17B | 4.28% | 2,170,160 | - |
| 168 | IVA | Inventiva S.A. | 1.11B | 1.29% | 356,408 | 7.94M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.06B | - | 379,921 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 1.06B | 0.29% | 244,874 | 24.00M |
| 171 | KURA | Kura Oncology, Inc. | 1.06B | 1.45% | 1,238,682 | 77.23M |
| 172 | WVE | Wave Life Sciences, Inc. | 1.05B | 1.52% | 1,832,538 | 65.37M |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.03B | 9.22% | 14,759,116 | 181.72M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 5.50% | 2,296,130 | 41.47M |
| 175 | SLDB | Solid Biosciences Inc. | 1.00B | 2.53% | 504,740 | - |
| 176 | CADL | Candel Therapeutics, Inc. | 990.15M | 4.78% | 962,901 | - |
| 177 | CLYM | Climb Bio, Inc. | 989.63M | 1.23% | 699,487 | - |
| 178 | GERN | Geron Corporation | 973.35M | -2.26% | 2,564,903 | 204.56M |
| 179 | ARDX | Ardelyx, Inc. | 973.08M | 0.13% | 1,895,307 | 450.89M |
| 180 | ANNX | Annexon, Inc. | 964.96M | -1.74% | 908,944 | - |
| 181 | IMMX | Immix Biopharma, Inc. | 960.06M | 1.98% | 1,115,841 | - |
| 182 | DSGN | Design Therapeutics, Inc. | 955.00M | -1.93% | 390,714 | - |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 954.58M | 2.45% | 945,108 | 8.22M |
| 184 | OLMA | Olema Pharmaceuticals, Inc. | 937.97M | -1.65% | 486,770 | - |
| 185 | ATTO | Attovia Therapeutics, Inc. | 901.03M | 3.61% | 304,411 | 1.35M |
| 186 | SGP | SpyGlass Pharma, Inc. | 893.40M | 1.83% | 37,825 | - |
| 187 | TBPH | Theravance Biopharma, Inc. | 883.14M | 0.35% | 570,360 | 104.31M |
| 188 | ANL | Adlai Nortye Ltd. | 879.35M | -0.47% | 81,339 | 18.06M |
| 189 | OBX | Obsidian Therapeutics, Inc. | 865.23M | -1.09% | 1,377,047 | - |
| 190 | DBVT | DBV Technologies S.A. | 862.94M | 2.88% | 110,128 | 5.04M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 856.85M | 1.37% | 193,599 | 276.79M |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 856.84M | -3.66% | 654,354 | 92.01M |
| 193 | PHAR | Pharming Group N.V. | 839.49M | 3.60% | 9,563 | 366.48M |
| 194 | FTH | Faeth Therapeutics, Inc. | 835.42M | 0.72% | 282,584 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 823.22M | -0.25% | 679,216 | - |
| 196 | OCS | Oculis Holding AG | 807.46M | -0.46% | 37,970 | 1.45M |
| 197 | SLN | Silence Therapeutics plc | 802.59M | 1.21% | 379,209 | 615.00K |
| 198 | AURA | Aura Biosciences, Inc. | 800.08M | -0.71% | 315,991 | - |
| 199 | DRUG | Bright Minds Biosciences Inc. | 783.53M | 0.20% | 134,278 | - |
| 200 | HELP | Cybin Inc. | 781.62M | 1.12% | 1,664,553 | - |
| 201 | NGNE | Neurogene Inc. | 762.98M | 0.36% | 291,985 | 925.00K |
| 202 | NVCT | Nuvectis Pharma, Inc. | 759.15M | -0.21% | 162,385 | - |
| 203 | STTK | Shattuck Labs, Inc. | 741.68M | 1.93% | 232,232 | 1.00M |
| 204 | TECX | Tectonic Therapeutic, Inc. | 736.03M | 4.44% | 137,885 | - |
| 205 | GYRE | Gyre Therapeutics, Inc. | 734.28M | -1.35% | 46,752 | 109.82M |
| 206 | CBIO | Crescent Biopharma, Inc. | 728.47M | 4.87% | 164,361 | 11.88M |
| 207 | CTMX | CytomX Therapeutics, Inc. | 727.78M | 1.52% | 1,531,293 | 18.30M |
| 208 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 725.98M | -0.28% | 109,064 | - |
| 209 | MNPR | Monopar Therapeutics Inc. | 723.91M | -2.73% | 124,198 | - |
| 210 | ALLO | Allogene Therapeutics, Inc. | 723.80M | -0.24% | 3,613,406 | 4.64M |
| 211 | RGNX | REGENXBIO Inc. | 708.32M | -2.98% | 637,716 | 174.48M |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 702.96M | 2.91% | 571,522 | 239.66M |
| 213 | ZVRA | Zevra Therapeutics, Inc. | 701.03M | -0.71% | 442,259 | 136.07M |
| 214 | ASMB | Assembly Biosciences, Inc. | 698.37M | 2.30% | 270,144 | 74.85M |
| 215 | PRLD | Prelude Therapeutics Incorporated | 684.92M | 2.31% | 376,876 | 22.42M |
| 216 | AGMB | AgomAb Therapeutics NV | 657.21M | -0.63% | 19,451 | - |
| 217 | VALN | Valneva SE | 656.66M | 2.64% | 18,920 | 163.30M |
| 218 | SCTX | Scribe Therapeutics Inc. | 654.97M | 5.76% | 139,317 | 36.28M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 645.58M | 7.12% | 182,359 | - |
| 220 | AUTL | Autolus Therapeutics plc | 644.11M | -1.63% | 1,984,838 | 117.39M |
| 221 | OABI | OmniAb, Inc. | 640.44M | 2.44% | 1,333,222 | 38.46M |
| 222 | CRMD | CorMedix Inc. | 637.58M | -0.61% | 693,513 | 462.25M |
| 223 | SGMT | Sagimet Biosciences Inc. | 636.19M | 0.54% | 594,932 | - |
| 224 | MDXG | MiMedx Group, Inc. | 631.14M | 0.70% | 520,898 | 355.17M |
| 225 | VSTM | Verastem, Inc. | 622.62M | 0.81% | 573,975 | 87.53M |
| 226 | EIKN | Eikon Therapeutics, Inc. | 613.69M | 5.40% | 401,408 | - |
| 227 | ARVN | Arvinas, Inc. | 609.40M | 3.27% | 638,537 | 316.70M |
| 228 | PRME | Prime Medicine, Inc. | 609.32M | 5.71% | 2,889,749 | 4.07M |
| 229 | ALT | Altimmune, Inc. | 608.84M | 6.10% | 5,129,563 | 31.00K |
| 230 | ZURA | Zura Bio Limited | 565.39M | 2.61% | 550,758 | - |
| 231 | ENTX | Entera Bio Ltd. | 554.92M | -0.47% | 321,660 | 42.00K |
| 232 | OVID | Ovid Therapeutics Inc. | 547.81M | 2.37% | 918,490 | 1.58M |
| 233 | SPRY | ARS Pharmaceuticals, Inc. | 547.46M | - | 762,791 | 116.93M |
| 234 | RZLT | Rezolute, Inc. | 536.96M | 10.30% | 5,526,543 | - |
| 235 | ARTV | Artiva Biotherapeutics, Inc. | 528.50M | -2.96% | 127,777 | 251.00K |
| 236 | CABA | Cabaletta Bio, Inc. | 527.29M | -2.51% | 3,619,363 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 518.87M | 3.20% | 471,297 | - |
| 238 | MPLT | MapLight Therapeutics, Inc. | 518.04M | -0.53% | 263,679 | - |
| 239 | EVMN | Evommune, Inc. | 504.46M | 2.43% | 195,893 | 10.00M |
| 240 | BLSM | BlossomHill Therapeutics, Inc. | 494.59M | 2.15% | 54,202 | - |
| 241 | CCCC | C4 Therapeutics, Inc. | 493.95M | -0.37% | 840,552 | 35.04M |
| 242 | RLMD | Relmada Therapeutics, Inc. | 493.88M | -0.22% | 599,929 | - |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 492.93M | 5.17% | 1,040,874 | 132.42M |
| 244 | PRTA | Prothena Corporation plc | 486.93M | 5.04% | 252,284 | 54.53M |
| 245 | EDIT | Editas Medicine, Inc. | 479.94M | 6.29% | 1,752,175 | 47.01M |
| 246 | PBYI | Puma Biotechnology, Inc. | 479.55M | 1.98% | 141,013 | 231.24M |
| 247 | PROK | ProKidney Corp. | 477.67M | 11.27% | 1,445,712 | 818.00K |
| 248 | QTTB | Q32 Bio Inc. | 476.31M | 0.88% | 209,301 | 53.74M |
| 249 | BNTC | Benitec Biopharma Inc. | 472.37M | 5.69% | 123,581 | - |
| 250 | OCGN | Ocugen, Inc. | 466.28M | -1.08% | 1,515,247 | 4.58M |
| 251 | EYPT | EyePoint, Inc. | 453.48M | -2.59% | 6,070,667 | 2.79M |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.95M | -0.89% | 151,617 | - |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 438.72M | 2.05% | 161,429 | - |
| 254 | IKT | Inhibikase Therapeutics, Inc. | 437.89M | 2.34% | 212,953 | 1.00 |
| 255 | LRMR | Larimar Therapeutics, Inc. | 434.75M | 0.12% | 366,893 | - |
| 256 | CMPX | Compass Therapeutics, Inc. | 425.91M | 0.21% | 1,096,569 | 850.00K |
| 257 | FHTX | Foghorn Therapeutics Inc. | 425.79M | 2.28% | 453,394 | 36.74M |
| 258 | VTVT | vTv Therapeutics Inc. | 408.28M | -0.67% | 23,231 | 36.84M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | 0.25% | 1,064,692 | 15.85M |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 398.73M | -3.95% | 345,230 | - |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 398.54M | 0.13% | 131,017 | 59.22M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 392.32M | 2.59% | 136,539 | 65.26M |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 389.15M | 1.87% | 583,300 | - |
| 264 | VOGX | Vogenx, Inc. | 384.13M | 16.70% | 343,721 | - |
| 265 | UPB | Upstream Bio, Inc. | 381.21M | 1.61% | 276,271 | 3.16M |
| 266 | ARCT | Arcturus Therapeutics Holdings Inc. | 380.87M | 21.93% | 2,404,318 | 29.37M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 377.50M | 0.36% | 78,138 | 27.00K |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 374.13M | - | 171 | 64.24M |
| 269 | GALT | Galectin Therapeutics Inc. | 372.14M | 3.36% | 130,474 | - |
| 270 | IPSC | Century Therapeutics, Inc. | 371.20M | 1.49% | 249,916 | 109.16M |
| 271 | PALI | Palisade Bio, Inc. | 366.84M | 2.18% | 744,049 | 500.00K |
| 272 | ZNTL | Zentalis Pharmaceuticals, Inc. | 364.01M | 0.13% | 522,032 | 26.87M |
| 273 | AGEN | Agenus Inc. | 361.51M | 7.21% | 748,193 | 132.69M |
| 274 | CAPR | Capricor Therapeutics, Inc. | 357.55M | -10.02% | 6,700,630 | 11.13M |
| 275 | IRD | Opus Genetics, Inc. | 356.91M | 4.13% | 760,909 | 9.86M |
| 276 | DMAC | DiaMedica Therapeutics Inc. | 353.21M | 0.46% | 52,164 | - |
| 277 | STRO | Sutro Biopharma, Inc. | 351.44M | 0.17% | 150,411 | 45.70M |
| 278 | ABEO | Abeona Therapeutics Inc. | 349.68M | 2.60% | 582,245 | 25.52M |
| 279 | IMRX | Immuneering Corporation | 345.81M | 1.81% | 337,349 | - |
| 280 | SABS | SAB Biotherapeutics, Inc. | 345.75M | 2.70% | 140,607 | 114.70K |
| 281 | YDES | YD Bio Limited | 336.83M | 0.09% | 32,196 | 510.36K |
| 282 | PRQR | ProQR Therapeutics N.V. | 333.05M | 3.96% | 593,634 | 21.05M |
| 283 | VCRE | Vicore Pharma Holding AB (publ) | 327.96M | -5.75% | 774 | 412.09K |
| 284 | VNDA | Vanda Pharmaceuticals Inc. | 323.48M | -0.56% | 441,437 | 215.72M |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 321.86M | -1.38% | 231,407 | 31.98M |
| 286 | RNAC | Cartesian Therapeutics, Inc. | 309.21M | -0.10% | 125,196 | 1.48M |
| 287 | NMRA | Neumora Therapeutics, Inc. | 308.15M | 8.25% | 363,071 | - |
| 288 | BCYC | Bicycle Therapeutics plc | 305.17M | 2.83% | 443,270 | 61.21M |
| 289 | IFRX | InflaRx N.V. | 305.05M | 2.48% | 361,838 | -11.54K |
| 290 | AVXL | Anavex Life Sciences Corp. | 303.04M | 4.47% | 335,085 | - |
| 291 | IVVD | Invivyd, Inc. | 294.02M | 4.91% | 4,856,437 | 58.37M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 292.98M | -0.26% | 930,745 | 80.00M |
| 293 | ACIU | AC Immune SA | 288.34M | 9.85% | 359,449 | 21.67M |
| 294 | FATE | Fate Therapeutics, Inc. | 286.97M | -2.24% | 760,431 | 6.49M |
| 295 | ALXO | ALX Oncology Holdings Inc. | 283.47M | 3.02% | 285,305 | - |
| 296 | CAMP | Camp4 Therapeutics Corporation | 281.76M | 0.67% | 64,452 | 4.22M |
| 297 | SRZN | Surrozen, Inc. | 280.32M | 1.49% | 82,907 | 11.51M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 280.22M | -2.13% | 417,235 | - |
| 299 | TTRX | Turn Therapeutics Inc. | 279.11M | -1.78% | 12,110 | - |
| 300 | LCTX | Lineage Cell Therapeutics, Inc. | 274.40M | 0.46% | 603,410 | 13.08M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 271.51M | -0.92% | 71,375 | 4.69M |
| 302 | ADAG | Adagene Inc. | 269.24M | -1.96% | 48,828 | 9.29M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 269.08M | -2.28% | 142,700 | 7.15M |
| 304 | PYXS | Pyxis Oncology, Inc. | 261.90M | 0.64% | 532,126 | 11.04M |
| 305 | SLGL | Sol-Gel Technologies Ltd. | 261.49M | 1.90% | 27,108 | 1.80M |
| 306 | MGNX | MacroGenics, Inc. | 259.90M | 0.25% | 159,307 | 175.14M |
| 307 | NAGE | Niagen Bioscience, Inc. | 254.93M | 2.06% | 241,185 | 129.08M |
| 308 | ALEC | Alector, Inc. | 253.46M | 0.44% | 332,805 | 13.86M |
| 309 | CLLS | Cellectis S.A. | 251.33M | - | 24,145 | 63.82M |
| 310 | GLSI | Greenwich LifeSciences, Inc. | 251.29M | 11.82% | 111,468 | - |
| 311 | CGEN | Compugen Ltd. | 251.02M | - | 395,653 | 74.00M |
| 312 | DTIL | Precision BioSciences, Inc. | 244.14M | 1.43% | 234,330 | 45.06M |
| 313 | CNXU | Conexeu Sciences Inc. | 243.77M | -3.39% | 312,746 | - |
| 314 | SION | Sionna Therapeutics, Inc. | 243.24M | -2.54% | 1,294,813 | - |
| 315 | NERV | Minerva Neurosciences, Inc. | 238.26M | 4.18% | 58,920 | - |
| 316 | NBP | NovaBridge Biosciences | 230.14M | 4.19% | 383,342 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 229.25M | -0.63% | 617,923 | - |
| 318 | RNA | Atrium Therapeutics, Inc. | 227.25M | -1.45% | 145,079 | 35.84M |
| 319 | TARA | Protara Therapeutics, Inc. | 226.04M | -1.92% | 150,139 | - |
| 320 | IMUX | Immunic, Inc. | 222.81M | 1.43% | 87,326 | - |
| 321 | CHRS | Coherus Oncology, Inc. | 221.71M | 8.71% | 1,255,026 | 50.94M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 219.62M | 0.52% | 152,523 | - |
| 323 | KROS | Keros Therapeutics, Inc. | 217.70M | 0.27% | 90,968 | 15.01M |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 216.62M | 1.94% | 286,429 | 29.10M |
| 325 | PEPG | PepGen Inc. | 216.44M | 2.97% | 525,577 | - |
| 326 | MSLE | Satellos Bioscience Inc. | 212.72M | -3.14% | 13,857 | - |
| 327 | ACOG | Alpha Cognition Inc. | 211.46M | 2.21% | 122,987 | 15.26M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 211.35M | 3.31% | 229,619 | 34.46M |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 202.37M | 1.57% | 97,868 | 2.00M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 198.05M | 4.07% | 401,742 | - |
| 331 | NGEN | NervGen Pharma Corp. | 196.77M | 3.98% | 454,065 | - |
| 332 | NKTX | Nkarta, Inc. | 195.89M | 10.73% | 936,592 | - |
| 333 | IPHA | Innate Pharma S.A. | 195.26M | 6.70% | 30,902 | 10.57M |
| 334 | KRRO | Korro Bio, Inc. | 194.82M | 2.08% | 28,853 | 2.38M |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | -0.42% | 453,405 | 80.62M |
| 336 | ARMP | Armata Pharmaceuticals, Inc. | 182.94M | 11.31% | 83,232 | 5.54M |
| 337 | CDXS | Codexis, Inc. | 181.78M | 5.06% | 974,733 | 77.68M |
| 338 | HUMA | Humacyte, Inc. | 180.12M | -4.84% | 5,956,650 | 2.12M |
| 339 | CRBU | Caribou Biosciences, Inc. | 179.57M | 4.04% | 986,133 | 10.04M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 174.50M | -0.90% | 568,424 | 1.50M |
| 341 | MDWD | MediWound Ltd. | 171.19M | 1.11% | 69,758 | 11.86M |
| 342 | INDP | Indaptus Therapeutics, Inc. | 165.22M | -10.14% | 1,039,997 | - |
| 343 | MOLN | Molecular Partners AG | 163.88M | 3.31% | 472 | 856.30K |
| 344 | MENS | Jyong Biotech Ltd. | 161.83M | 0.93% | 14,299 | - |
| 345 | OKUR | OnKure Therapeutics, Inc. | 159.68M | 0.33% | 39,264 | - |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 157.07M | 1.45% | 983,263 | 1.34M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 156.55M | 3.12% | 840,944 | - |
| 348 | KZIA | Kazia Therapeutics Limited | 150.84M | -3.44% | 122,008 | 1.27M |
| 349 | AARD | Aardvark Therapeutics, Inc. | 149.25M | 15.79% | 146,620 | - |
| 350 | LENZ | LENZ Therapeutics, Inc. | 148.74M | 1.59% | 262,985 | 21.48M |
| 351 | MIST | Milestone Pharmaceuticals Inc. | 147.96M | 1.94% | 1,704,707 | 2.34M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 147.36M | 2.63% | 356,674 | 2.95M |
| 353 | NRXP | NRx Pharmaceuticals, Inc. | 147.11M | - | 436,427 | 3.39M |
| 354 | EQ | Equillium, Inc. | 145.97M | 1.41% | 450,161 | 4.39M |
| 355 | TLSA | Tiziana Life Sciences Ltd | 144.82M | - | 778,888 | - |
| 356 | SPRB | Spruce Biosciences, Inc. | 144.79M | -3.09% | 30,095 | 697.00K |
| 357 | PMN | ProMIS Neurosciences, Inc. | 130.84M | -2.15% | 3,101 | - |
| 358 | CBUS | Cibus, Inc. | 130.69M | 0.59% | 78,989 | 4.35M |
| 359 | HURA | TuHURA Biosciences, Inc. | 129.59M | -8.33% | 225,302 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 126.69M | 2.56% | 515,416 | 70.00M |
| 361 | VANI | Vivani Medical, Inc. | 126.28M | -0.71% | 88,867 | - |
| 362 | ANIX | Anixa Biosciences, Inc. | 126.23M | 3.34% | 156,323 | - |
| 363 | GUTS | Fractyl Health, Inc. | 124.10M | 13.79% | 3,251,354 | 3.00K |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 121.06M | 2.06% | 550,931 | 4.88M |
| 365 | OTLK | Outlook Therapeutics, Inc. | 121.04M | -4.29% | 9,893,743 | -1.16M |
| 366 | GNLX | Genelux Corporation | 120.99M | -1.46% | 138,192 | 8.00K |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 120.98M | -3.31% | 4,277,272 | 65.34K |
| 368 | NAUT | Nautilus Biotechnology, Inc. | 120.35M | 4.81% | 743,275 | 190.00K |
| 369 | ENGN | enGene Therapeutics Inc. | 119.58M | 0.85% | 171,448 | - |
| 370 | NTHI | NeOnc Technologies Holdings, Inc. | 114.47M | 0.99% | 115,609 | 39.99K |
| 371 | COYA | Coya Therapeutics, Inc. | 113.53M | -0.41% | 51,071 | 8.02M |
| 372 | SEER | Seer, Inc. | 112.68M | 0.74% | 97,865 | 14.22M |
| 373 | ONCY | Oncolytics Biotech Inc. | 105.85M | 3.54% | 425,805 | - |
| 374 | PLYX | Polaryx Therapeutics, Inc. | 105.67M | -0.93% | 99,642 | - |
| 375 | PYPD | PolyPid Ltd. | 102.98M | -0.20% | 157,943 | - |
| 376 | YARW | Yarrow Bioscience, Inc. | 101.25M | -5.34% | 25,008 | - |
| 377 | TENX | Tenax Therapeutics, Inc. | 100.24M | -1.69% | 3,144,586 | - |
| 378 | KLRS | Kalaris Therapeutics, Inc. | 99.98M | 1.94% | 63,921 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 99.92M | -2.10% | 14,991 | 43.30M |
| 380 | CUE | Cue Biopharma, Inc. | 99.36M | -3.88% | 120,855 | 37.66M |
| 381 | ACET | Adicet Bio, Inc. | 98.99M | -1.96% | 63,911 | - |
| 382 | BMEA | Biomea Fusion, Inc. | 98.58M | - | 500,949 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 95.06M | 0.96% | 16,753 | 6.19M |
| 384 | FBIO | Fortress Biotech, Inc. | 95.05M | 2.89% | 151,424 | 68.47M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 94.71M | 0.45% | 254,263 | - |
| 386 | CGTX | Cognition Therapeutics, Inc. | 93.68M | 2.97% | 287,471 | - |
| 387 | ALDX | Aldeyra Therapeutics, Inc. | 92.30M | 2.00% | 579,983 | - |
| 388 | ICCC | ImmuCell Corporation | 91.55M | -0.10% | 7,787 | 30.68M |
| 389 | RLYB | Rallybio Corporation | 88.50M | 0.39% | 3,649 | 646.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 86.63M | 0.25% | 201,141 | - |
| 391 | ELOX | Eloxx Pharmaceuticals, Inc. | 84.77M | 16.41% | 86,572 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 84.55M | 0.72% | 340,617 | - |
| 393 | DWTX | Dogwood Therapeutics, Inc. | 83.11M | 4.94% | 120,722 | - |
| 394 | OKYO | OKYO Pharma Limited | 81.87M | 2.63% | 9,359 | - |
| 395 | VRCA | Verrica Pharmaceuticals Inc. | 80.91M | -3.09% | 58,780 | 30.32M |
| 396 | ELTX | Elicio Therapeutics, Inc. | 79.90M | -1.14% | 216,362 | - |
| 397 | CING | Cingulate Inc. | 79.54M | 2.63% | 187,445 | - |
| 398 | NRXS | NeurAxis, Inc. | 77.86M | -1.12% | 81,996 | 5.32M |
| 399 | ANVS | Annovis Bio, Inc. | 77.00M | 1.12% | 553,838 | - |
| 400 | TELO | Telomir Pharmaceuticals, Inc. | 76.97M | -0.96% | 36,747 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 76.40M | 3.37% | 5,385 | 4.43M |
| 402 | GOSS | Gossamer Bio, Inc. | 74.60M | -3.11% | 126,417,289 | 53.29M |
| 403 | LONA | LeonaBio, Inc. | 72.42M | 0.13% | 4,723 | - |
| 404 | IBIO | iBio, Inc. | 71.79M | -1.70% | 652,271 | 300.00K |
| 405 | SPRO | Spero Therapeutics, Inc. | 71.34M | 1.24% | 284,562 | 47.00M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 71.21M | 2.68% | 462,469 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 71.20M | 2.69% | 86,324 | - |
| 408 | CRDF | Cardiff Oncology, Inc. | 70.56M | -0.19% | 507,724 | 508.00K |
| 409 | OSTX | OS Therapies Incorporated | 69.70M | -0.95% | 323,192 | - |
| 410 | CSBR | Champions Oncology, Inc. | 69.61M | -3.28% | 7,030 | 59.43M |
| 411 | XBIT | XBiotech Inc. | 69.51M | -1.30% | 9,534 | - |
| 412 | SER | Serina Therapeutics, Inc. | 69.35M | 3.02% | 23,660 | 130.00K |
| 413 | RNTX | Rein Therapeutics Inc. | 69.31M | 2.10% | 443,375 | - |
| 414 | MNOV | MediciNova, Inc. | 68.90M | 2.18% | 23,276 | 920.48K |
| 415 | EXOZ | eXoZymes, Inc. | 67.89M | 3.91% | 9,360 | -700.00 |
| 416 | BOLD | Boundless Bio, Inc. | 67.78M | 2.76% | 122,023 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 65.31M | 1.46% | 56,846 | 11.43M |
| 418 | BSEM | BioStem Technologies, Inc. | 64.79M | -1.36% | 58,537 | 34.59M |
| 419 | IMA | ImageneBio, Inc. | 64.48M | 1.25% | 17,072 | 800.00K |
| 420 | INMB | INmune Bio Inc. | 63.83M | 6.48% | 474,092 | 50.00K |
| 421 | XLO | Xilio Therapeutics, Inc. | 61.39M | 1.08% | 4,386 | 64.09M |
| 422 | HRTX | Heron Therapeutics, Inc. | 60.64M | 3.37% | 2,448,576 | 151.18M |
| 423 | RNXT | RenovoRx, Inc. | 59.35M | -0.38% | 218,919 | 1.98M |
| 424 | INKT | MiNK Therapeutics, Inc. | 59.28M | 2.41% | 11,018 | - |
| 425 | IMMP | Immutep Limited | 55.61M | -1.00% | 97,788 | 5.28M |
| 426 | NTRB | Nutriband Inc. | 55.19M | 19.00% | 48,069 | 1.80M |
| 427 | TCRX | TScan Therapeutics, Inc. | 52.75M | 0.27% | 120,276 | 7.11M |
| 428 | APLM | Apollomics, Inc. | 51.87M | 0.21% | 6,135 | 8.84M |
| 429 | TIL | Instil Bio, Inc. | 51.34M | 1.88% | 6,183 | - |
| 430 | ATYR | aTyr Pharma, Inc. | 50.48M | 2.31% | 331,802 | 190.00K |
| 431 | VRXA | Veraxa Biotech AG | 49.93M | 4.76% | 68,725 | - |
| 432 | IBO | Impact BioMedical Inc. | 49.66M | 2.50% | 21,389 | 35.00K |
| 433 | HYPD | Hyperion DeFi, Inc. | 48.95M | 0.32% | 706,408 | 1.40M |
| 434 | MREO | Mereo BioPharma Group plc | 47.15M | 0.66% | 571,878 | 500.00K |
| 435 | CNTX | Context Therapeutics Inc. | 46.77M | -2.06% | 1,249,872 | - |
| 436 | ALPS | Alps Group Inc | 46.58M | 3.67% | 8,363 | 3.74M |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 46.47M | 2.50% | 298,717 | 13.56M |
| 438 | FLNA | Filana Therapeutics, Inc. | 46.00M | 1.03% | 94,064 | - |
| 439 | GRCE | Grace Therapeutics, Inc. | 45.86M | 1.87% | 69,371 | - |
| 440 | MCRB | Seres Therapeutics, Inc. | 45.23M | -0.44% | 37,978 | 1.88M |
| 441 | VERU | Veru Inc. | 45.05M | 2.40% | 157,789 | 16.89M |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 44.23M | 7.14% | 727,013 | 146.62M |
| 443 | HOWL | Werewolf Therapeutics, Inc. | 43.95M | 109.72% | 281,492,098 | 21.00M |
| 444 | EDSA | Edesa Biotech, Inc. | 42.66M | -7.04% | 150,233 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 41.84M | 4.04% | 31,277 | 31.52M |
| 446 | CRVO | CervoMed Inc. | 39.31M | 1.56% | 238,244 | 331.30K |
| 447 | LITS | Lite Strategy, Inc. | 35.22M | 9.71% | 289,736 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 34.90M | -0.89% | 135,474 | 35.09M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 34.61M | 2.80% | 120,793 | - |
| 450 | ESLA | Estrella Immunopharma, Inc. | 32.62M | 0.66% | 7,579 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 32.34M | 2.99% | 7,160 | - |
| 452 | IGC | IGC Pharma, Inc. | 31.55M | 10.10% | 1,702,945 | 1.11M |
| 453 | RADX | Radiopharm Theranostics Limited | 30.88M | 7.42% | 46,361 | 10.86M |
| 454 | ACTU | Actuate Therapeutics, Inc. | 30.86M | 4.88% | 231,546 | - |
| 455 | NNVC | NanoViricides, Inc. | 30.64M | 2.67% | 187,243 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 30.08M | 1.50% | 31,024 | 4.62M |
| 457 | GNTA | Genenta Science S.p.A. | 29.96M | 6.72% | 17,897 | - |
| 458 | BYSI | BeyondSpring Inc. | 29.89M | 0.96% | 53,695 | 1.88M |
| 459 | LTRN | Lantern Pharma Inc. | 29.79M | 1.75% | 164,300 | - |
| 460 | NXTC | NextCure, Inc. | 29.20M | 2.08% | 27,852 | - |
| 461 | TVGN | Tevogen Inc. | 28.23M | 5.02% | 11,273 | - |
| 462 | QNTM | Quantum BioPharma Ltd. | 28.18M | -0.29% | 121,561 | - |
| 463 | EVAX | Evaxion A/S | 27.67M | 1.14% | 429,667 | 7.49M |
| 464 | LGVN | Longeveron Inc. | 26.78M | 1.44% | 721,715 | 1.19M |
| 465 | ENLV | Enlivex Ltd. | 25.88M | -1.33% | 146,500 | - |
| 466 | ATOS | Atossa Therapeutics, Inc. | 25.49M | -1.39% | 19,886 | - |
| 467 | GRDX | GridAI Technologies Corp. | 25.42M | -4.27% | 111,356 | - |
| 468 | CVM | CEL-SCI Corporation | 25.34M | -0.68% | 58,532 | - |
| 469 | DYAI | Dyadic International, Inc. | 25.15M | -1.41% | 98,084 | 3.80M |
| 470 | BRNS | Barinthus Biotherapeutics plc | 25.02M | 0.03% | 11,597 | 14.97M |
| 471 | CLRB | Cellectar Biosciences, Inc. | 24.34M | -0.58% | 25,188 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 23.24M | 1.27% | 599,382 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 23.01M | 13.11% | 87,458 | 2.69M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 22.59M | -0.70% | 105,973 | 345.00K |
| 475 | ABVC | ABVC BioPharma, Inc. | 22.57M | -2.17% | 38,928 | 797.92K |
| 476 | CELU | Celularity Inc. | 22.34M | 0.63% | 24,559 | 26.55M |
| 477 | COCP | Cocrystal Pharma, Inc. | 21.57M | -4.27% | 59,367 | 330.00K |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 21.35M | - | 177,996 | -13.27K |
| 479 | CNSY | Cerenome, Inc. | 20.92M | 1.33% | 89,133 | 4.20M |
| 480 | PLRZ | Polyrizon Ltd. | 20.10M | 2.38% | 20,175 | - |
| 481 | CALC | CalciMedica, Inc. | 19.46M | -2.26% | 235,981 | - |
| 482 | PLUR | Pluri Inc. | 19.31M | 1.12% | 3,291 | 1.08M |
| 483 | PTN | Palatin Technologies, Inc. | 19.04M | -1.18% | 3,824 | 12.88M |
| 484 | NCEL | NewcelX Ltd. | 18.41M | 1.48% | 1,356 | - |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 18.29M | -2.46% | 59,811 | 1.90M |
| 486 | LEXX | Lexaria Bioscience Corp. | 18.03M | -3.19% | 7,957 | 194.00K |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 17.73M | 3.28% | 128,055 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 17.44M | 11.06% | 245,908 | - |
| 489 | LPCN | Lipocine Inc. | 16.98M | -1.44% | 17,722 | 1.57M |
| 490 | TPST | Tempest Therapeutics, Inc. | 16.62M | 1.96% | 115,118 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.54M | 0.44% | 124,886 | 7.11M |
| 492 | HIND | Vyome Holdings, Inc. | 16.21M | 1.32% | 3,034 | 129.73K |
| 493 | PBM | Psyence Biomedical Ltd. | 15.98M | 6.62% | 68,203 | - |
| 494 | KALA | KALA BIO, Inc. | 15.92M | 1.95% | 93,699 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 15.64M | -1.84% | 14,052 | - |
| 496 | AKTX | Akari Therapeutics, Plc | 15.47M | 1.99% | 10,589 | - |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 15.36M | 2.42% | 92,683 | - |
| 498 | BCDA | BioCardia, Inc. | 15.14M | 3.40% | 46,489 | 3.00K |
| 499 | ICU | SeaStar Medical Holding Corporation | 15.03M | 2.10% | 53,569 | 1.71M |
| 500 | MLEC | Moolec Science SA | 14.86M | 2.63% | 7,444 | 7.83M |